A share price of Cg Oncology Inc [CGON] is currently trading at $43.25, down -2.72%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CGON shares have gain 8.61% over the last week, with a monthly amount glided 30.43%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on October 08, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $90. Previously, Piper Sandler started tracking the stock with Overweight rating on August 19, 2025, and set its price target to $55. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $41 on May 02, 2025. Scotiabank initiated its recommendation with a Sector Perform and recommended $23 as its price target on April 16, 2025. In a note dated October 24, 2024, UBS initiated a Buy rating and provided a target price of $60 on this stock.
Cg Oncology Inc experienced fluctuations in its stock price throughout the past year between $14.80 and $44.47. Currently, Wall Street analysts expect the stock to reach $74.67 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $43.25 at the most recent close of the market. An investor can expect a potential return of 72.65% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Trailing Twelve Months sales for Cg Oncology Inc [NASDAQ:CGON] were 0.55M which represents -100.00% decline. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at -285.46%, Pretax Profit Margin comes in at -232.45%, and Net Profit Margin reading is -157.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.13 and Total Capital is -0.23. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cg Oncology Inc [NASDAQ:CGON] is 22.15. As well, the Quick Ratio is 22.15, while the Cash Ratio is 0.48. Considering the valuation of this stock, the price to sales ratio is 5995.84, the price to book ratio is 4.92.
Transactions by insiders
Recent insider trading involved Mulay James, Director, that happened on Oct 09 ’25 when 5903.0 shares were sold. Director, JAMES MULAY completed a deal on Oct 09 ’25 to buy 6557.0 shares. Meanwhile, Director POST LEONARD E sold 5000.0 shares on Sep 30 ’25.
